Director’s Dealings

Cardiogeni PLC

28 February 2025

 

28 February 2025

Cardiogeni PLC

("Cardiogeni" or the "Company")

Director's Dealings

Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans to advance novel heart failure medicines through human trials, announces that Darrin Disley, Executive Chairman of Cardiogeni has purchased a total of 152,205 ordinary shares of the Company, the details of which are set out in the notification below.

Following the purchase, Darrin Disley will hold 2,816,017 ordinary shares representing 3.30% of Cardiogeni's issued share capital.

The directors of Cardiogeni accept responsibility for this announcement.

This announcement, including the notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.

For further information please contact:

Cardiogeni PLC
Dr Darrin M Disley OBE, Executive Chairman	Via First Sentinel
First Sentinel Corporate Finance Limited Corporate Adviser
Brian Stockbridge Gabrielle Cordeiro	[phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Darrin Disley
2.	Reason for the Notification
a)	Position/status	Executive Chairman
b)	Initial notification / Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cardiogeni PLC
b)	LEI	9845000F8F59ATZD8F92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument	Ordinary shares
	ISIN	GB00BTBLFC12
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Date Price(s) Volume(s)  1.    25-02-2025 £0.15 50,000 2.    26-02-2025 £0.22 60,000 3.    27-02-2025 £0.22 £0.22 40,000 2,205
d)	Aggregated information:  · Aggregated volume  · Price	Aggregated volume: 152,205 Price: £0.197
e)	Date of the transaction	25/02/2025 to 27/02/2025
f)	Place of the Transaction	Aquis Exchange Growth Market (AQSE)

 

 

END